# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-23-006560
Filing Date
2023-03-08
Accepted
2023-03-07 21:16:35
Documents
4
Period of Report
2023-05-17

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | prelim_proxy-2023.htm | PRE 14A | 1903059
2 | GRAPHIC | img64779120_0.jpg | GRAPHIC | 118707
3 | GRAPHIC | img64779120_1.jpg | GRAPHIC | 499315
4 | GRAPHIC | img64779120_2.jpg | GRAPHIC | 212002
| Complete submission text file | 0000950170-23-006560.txt |  | 3047519

Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37378 | Film No.: 23714700
SIC: 2836 Biological Products, (No Diagnostic Substances)